Homepage
On-Demand Webinar: Navigating the ADC Development Pathway
Our latest webinar offers a comprehensive perspective on strategies crucial to accelerating the development of antibody-drug conjugates
Video: End-to-End CRDMO Platform for Oligonucleotide Drugs
Learn about our our oligonucleotide platform, covering everything from drug discovery to commercial manufacturing
Article: Unlocking Peptide Discovery with mRNA Display
In our latest article, we explore the principles and key steps of mRNA display, as well as its application in peptide discovery and screening.
WuXi Biology
A full spectrum of biology services and solutions, supporting stand-alone and integrated projects, from target discovery to candidate selection and into the clinic
Enabling Unbounded Possibilities
WuXi Biology provides a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and beyond. Our world-class discovery platform is backed by nearly 3,000 scientists, offering expertise in all major disease areas and target classes, across all therapeutic modalities. From small molecules and oligonucleotides to peptides and antibodies, our state-of-the-art services, fast turnaround times, and quick study launches meet the diverse needs of our clients.
Speak with a SpecialistTarget Discovery to Candidate Selection and Beyond
Supporting stand-alone and integrated projects
Comprehensive platform from target ID to drug candidates
Target Identification and Validation
Finding druggable targets
Comprehensive coverage of target classes and therapeutic modalities
Hit Identification
Screening services to accelerate drug discovery
Integrated platform with diverse methods to identify hit compounds
Hit Validation and Early Optimization
Confirming chemistry tractability
In vitro screening platform to support medicinal chemistry
Lead Discovery Services
Enhancing the most promising compounds
In vivo services to accelerate drug discovery
Preclinical Drug Development
Enabling the selection of the best candidates
Integrated platform for preclinical R&D to accelerate timelines
Investigational New Drug Discovery
Comprehensive IND enabling testing platform
Supporting clients from research to market
Latest Science
Latest Poster
Efficacy of a TL1A Antibody in an Acute...
Efficacy of a TL1A Antibody in an Acute Colitis Mouse Model
VIEW PosterLatest Webinar
Navigating the ADC Development Pathway
Navigating the ADC Development Pathway
VIEW WebinarLatest Poster
GLP1R and GIPR Dual-Target Drugs in Humanized GIPR...
GLP1R and GIPR Dual-Target Drugs in Humanized GIPR Mice
VIEW PosterLatest Poster
MSU-Induced Acute Gouty Arthritis Mouse Model
MSU-Induced Acute Gouty Arthritis Mouse Model
VIEW PosterEvaluations of Targeted Delivery Systems for RNA Therapeutics
VIEW PosterLatest Video
End-to-End CRDMO Platform for Oligonucleotide Drugs
End-to-End CRDMO Platform for Oligonucleotide Drugs
VIEW VideoLatest Poster
Integrated Platform Supporting ASO Drug Discovery
Integrated Platform Supporting ASO Drug Discovery
VIEW PosterLatest Poster
Evaluating Off-Targets of siRNA Drugs
Evaluating Off-Targets of siRNA Drugs
VIEW PosterLatest Article
DLL3‑related Tumor Models in Humanized Mice
DLL3‑related Tumor Models in Humanized Mice
VIEW ArticleLatest Poster
Efficacy of a Cell Therapy Drug on Kainic...
Efficacy of a Cell Therapy Drug on Kainic Acid-Induced Seizures
VIEW Poster
